Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

  Email address:
   

Recent Articles in Gov't & Regulatory

China to Audit 77 Pharmas after Kangmei Reports $4.4 Billion Fraud
Sandoz Approved to Launch Crestor, a Generic Statin, in China
Hong Kong's Pre-Revenue China Biotech IPOs: A Tale of Two Markets
China Negotiates Shorter Exclusivity for US-Made Biologic Drugs
FDA Official Tells China Biopharmas to Bring PD-1/PD-L1 Inhibitors to US
ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes


Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China